Giulia Scorrano

[Wiley Clinical and Health @WileyHealth]

September is #SickleCellAwarenessMonth

Explore this Sickle Cell Virtual Issue of curated articles from the @BritSocHaem Journals: https://t.co/yCHuCzR3Js

@BrJHaem @e_JHaem @DrAEvens @scheinbp @ElHoss_Sara @giulia_scr682

[eJHaem Journal @e_JHaem]

🎉 Thrilled to announce that eJHaem has received its first Impact Factor of 1.2! A huge thank you to our authors, reviewers & readers for making this possible.
Join us in advancing hematology research, submit your work today!
https://t.co/iK76vuYBo6
@WileyOnc_Hem @BritSocHaem

[Wiley Clinical and Health @WileyHealth]

As the new Editor-in-Chief of @e_JHaem - the #OpenAccess journal of the @BritSocHaem - Dr. Phil Scheinberg (@scheinbp) outlines his vision for the journal in an introductory editorial.

Read it here! ➡️ https://t.co/A4CgS0ZDcp

@ElHoss_Sara @giulia_scr682

[British Journal of Haematology @BrJHaem]

@BrJHaem wishes you a Happy New Year !! ✨
Let's begin 2025 with our #MeetTheEditor series Episode 4 by introducing you to our #AssociateEditor Cheng-Hock Toh ! Stay tuned! #BrJHaem #Haematology @wileyOnc_Hem @BritSocHaem

[British Journal of Haematology @BrJHaem]

Happening now at #ASH24 our social media editor @ElHoss_Sara interviewing our newly appointed editor in chief @DrAEvens ! Stay tuned to hear about Dr Evens vision for the journal @WileyOnc_Hem @BritSocHaem @RutgersCancer @RWJBarnabas

[eJHaem Journal @e_JHaem]

Happening at #ASH24 ! Our social media editor interviewing our newly appointed editor in chief Dr Phillip Scheinberg! Stay tuned to learn more about Dr Scheinberg and his vision for eJHaem @scheinbp @ElHoss_Sara

[British Journal of Haematology @BrJHaem]

📣 We're excited to introduce you to our #AssociateEditor Arnold Ganser for our #MeetTheEditor Episode 3! Stay tuned! #BrJHaem #Haematology
@wileyOnc_Hem @BritSocHaem

[British Journal of Haematology @BrJHaem]

📣 #MeetTheEditor Episode 2! We're excited to introduce you to our #AssociateEditor Peter Hokland. Stay tuned! #BrJHaem #Haematology

@wileyOnc_Hem @BritSocHaem @HoklandPeter

[Science News @SciencNews]

Guidelines for Writing a Journal Article

#PhD #PhDlife #academics #AcademicChatter #AcademicTwitter #Postdocs #Research #Science

[British Journal of Haematology @BrJHaem]

🎉 Kicking off our #MeetTheEditor series with Episode 1! We're excited to introduce you to our #AssociateEditor Phillip Scheinberg. Get to know what excites them most in the field of haematology. Stay tuned! #BrJHaem #Haematology

@wileyOnc_Hem @BritSocHaem @scheinbp

[Wiley Clinical and Health @WileyHealth]

This Good Practice Paper published in @BrJHaem provides recommendations for the diagnosis and initial management of transplant-eligible high-risk #myeloma patients: https://t.co/FbuvZqgXG9

#BloodCancerAwareness 🩸

@MyMKaiser @DrSStern @JennerMatthew @BritSocHaem @ElHoss_Sara

[Wiley Clinical and Health @WileyHealth]

This @BritSocHaem guideline summarizes the recommended initial investigation and first-line management of large B-cell #lymphoma:

https://t.co/IM703bQHPc

#BloodCancerAwarenessMonth 🩸

@DrChrisPFox @SridharChaganti @CwynKate @pammckay123 @BrJHaem @ElHoss_Sara @giulia_scr682

[Blood Advances @BloodAdvances]

Stratification of patients with AML using LSC score (LSC-17) is improved by the score associated with AP-1/TNF-α gene signature. https://t.co/FqEnIH5Z9q #myeloidneoplasia #hematopoiesisandstemcells

[Wiley Clinical and Health @WileyHealth]

#BloodCancerAwarenessMonth | Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease

#OpenAccess ➡️ https://t.co/whtwS2uRZk

@BrJHaem
@BritSocHaem
@giulia_scr682
@ElHoss_Sara

[eJHaem Journal @e_JHaem]

Stable engraftment, as well as graft versus host disease-free and relapse-free survival brought by the combination of CD7 targeted universal chimeric antigen receptor-T, and donor hemopoietic stem cells: Indication of a case report
https://t.co/N0P9MAl4yi

[eJHaem Journal @e_JHaem]

Low-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignancies
https://t.co/1PTY8XC8WN

[eJHaem Journal @e_JHaem]

Haematology images: B-lymphoblastic leukemia/lymphoma with DUX4 rearrangement
https://t.co/xSyb1uPrTz

[Rafa Argüello @RafaJArguello]

🚀🔥[1/5] Exciting news! Registration for our highly anticipated workshop is OFFICIALLY OPEN! 🎉We're thrilled to share an updated program featuring even MORE incredible speakers!
Also, we're proud to announce our first confirmed company sponsors, @CytekBio!
@sfiimmunologie